REVIEW - NEW DIRECTIONS IN THE OPTIMIZATION OF OCULAR DRUG DELIVERY

被引：56

作者：

LEE, VHL

机构：

[1] University of Southern California, School of Pharmacy, Los Angeles, CA

来源：

JOURNAL OF OCULAR PHARMACOLOGY | 1990年 / 6卷 / 02期

关键词：

D O I：

10.1089/jop.1990.6.157

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

The main effort in ocular drug delivery during the past two decades has been on the design of systems to prolong the residence time of topically applied drugs in the conjunctival sac. Four recent developments promise to chart a new course in ocular drug delivery research: collagen shield as a topical ocular drug delivery system, in-situ activated gel-forming systems, noncorneal route of ocular drug penetration, and need for minimizing the systemic absorption of topically applied drugs. © 1990, Mary Ann Liebert, Inc. All rights reserved.

引用

页码：157 / 164

页数：8

共 46 条

[1] Lee V.H.L., Robinson J.R., Topical ocular drug delivery: recent developments and future challenges, J. Ocular Pharmacoo, 2, pp. 67-108, (1986)
[2] Shaker G.J., Ueda S., LoCascio J.A., Aquavella J.V., Effect of a collagen shield on cat corneal epithelial wound healing, Invest, Ophthalmol. Vis. Sci, 30, pp. 1565-1568, (1989)
[3] Eswein M.B., O'Brien T.P., Osato M.S., Jones D.B., Antimicrobial efficacy of antiseptic-containing collagen corneal shields, Invest, Ophthalmol. Vis. Sci, 31, (1990)
[4] Desai D., Thomas J., Rockey J.H., Sahm D., Use of medicated collagen shields in the treatment of experimental Acanthamoeba keratttis, Invest, Ophthalmol. Vis. Sci, 31, (1990)
[5] Sawusch M.R., O'Brien T.P., Dick J.D., Gottsch J.D., Use of collagen corneal shields in the treatment of bacterial keratttis, Am, J. Ophthalmol, 106, pp. 279-281, (1988)
[6] Schwartz S.D., Harrison S.A., Engstrom R.E., Bawden R.E., Lee D.A., Mondino B.J., Amphoteercin B delivery by collagen shields, Invest, Ophthalmol. Vis. Sci, 31, (1990)
[7] Gussler J.R., Ashton P., Van Meter W.S., Smith T.J., The effect of collagen shields on the topical delivery of trifluorothymidine into cornea and aqueous, Invest, Ophthalmol. Vis Sci, 31, (1990)
[8] Finkelstein I., Trope G.E., Menon I.A., Spero L., Rootman D.S., Heathcote G., Further evaluation of collagen shields as adelivery system for 5-fluorouracil (5-FU): Histopathological observations, Invest, Ophtalmol. Vis. Sci, 31, (1990)
[9] Jacob-LaBarre J.T., Kaufman H.E., Investigation of pilocarpine-loaded polybutylcyanoacrylate nanocapsules in collagen shields as a drug delivery system, Invest, Ophthalmol. Vis. Sci, 31, (1990)
[10] Ellis P.P., Matsumura M., Rendi M.A., Pilocarpine concentration in aqueous humor following single drop application

← 1 2 3 4 5 →